Publikationen von Mathias V. Schmidt

Scharf, S. H.; Sterlemann, V.; Liebl, C.; Mueller, M. B.; Schmidt, M. V.: Chronic social stress during adolescence: Interplay of paroxetine treatment and ageing. NEUROPHARMACOLOGY 72, S. 38 - 46 (2013)

Kollmannsberger, L. K.; Gassen, N. C.; Bultmann, A.; Hartmann, J.; Weber, P.; Schmidt, M. V.; Rein, T.: Increased Glyoxalase-1 Levels in Fkbp5 Knockout Mice Caused by Glyoxalase-1 Gene Duplication. G3-GENES GENOMES GENETICS 3 (8), S. 1311 - 1313 (2013)

Wang, X.-D.; Su, Y.-A.; Wagner, K. V.; Avrabos, C.; Scharf, S. H.; Hartmann, J.; Wolf, M.; Liebl, C.; Kühne, C.; Wurst, W. et al.; Holsboer, F.; Eder, M.; Deussing, J. M.; Müller, M. B.; Schmidt, M. V.: Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss. NATURE NEUROSCIENCE 16 (6), S. 706 - 713 (2013)

Maurin, H.; Seymour, C. M.; Lechat, B.; Borghgraef, P.; Devijver, H.; Jaworski, T.; Schmidt, M. V.; Kuegler, S.; Van Leuven, F.: Tauopathy Differentially Affects Cell Adhesion Molecules in Mouse Brain: Early Down-Regulation of Nectin-3 in Stratum Lacunosum Moleculare. PLOS ONE 8 (5), e63589 (2013)

Di Benedetto, B.; Radecke, J.; Schmidt, M. V.; Rupprecht, R.: ACUTE ANTIDEPRESSANT TREATMENT DIFFERENTLY MODULATES ERK/MAPK ACTIVATION IN NEURONS AND ASTROCYTES OF THE ADULT MOUSE PREFRONTAL CORTEX. NEUROSCIENCE 232, S. 161 - 168 (2013)

Wagner, K. V.; Hartmann, J.; Mangold, K.; Wang, X.-D.; Labermaier, C.; Liebl, C.; Wolf, M.; Gassen, N. C.; Holsboer, F.; Rein, T. et al.; Müller, M. B.; Schmidt, M. V.: Homer1 Mediates Acute Stress-Induced Cognitive Deficits in the Dorsal Hippocampus. JOURNAL OF NEUROSCIENCE 33 (9), S. 3857 - 3864 (2013)

Kohl, C.; Riccio, O.; Grosse, J.; Zanoletti, O.; Fournier, C.; Schmidt, M. V.; Sandi, C.: Hippocampal Neuroligin-2 Overexpression Leads to Reduced Aggression and Inhibited Novelty Reactivity in Rats. PLOS ONE 8 (2), e56871 (2013)

Wagner, K. V.; Marinescu, D.; Hartmann, J.; Wang, X. D.; Labermaier, C.; Scharf, S. H.; Liebl, C.; Uhr, M.; Holsboer, F.; Müller, M. B. et al.; Schmidt, M. V.: Differences in FKBP51 Regulation Following Chronic Social Defeat Stress Correlate with Individual Stress Sensitivity: Influence of Paroxetine Treatment. Neuropsychopharmacology 37 (13), S. 2797 - 2808 (2012)

Schmidt, M. V.; Paez-Pereda, M.; Holsboer, F.; Hausch, F.: The Prospect of FKBP51 as a Drug Target. ChemMedChem 7 (8), S. 1351 - 1359 (2012)

Nederhof, E.; Schmidt, M. V.: Mismatch or cumulative stress: Toward an integrated hypothesis of programming effects. Physiology & Behavior 106 (5), S. 691 - 700 (2012)

Scharf, S. H.; Schmidt, M. V.: Animal Models of Stress Vulnerability and Resilience in Translational Research. Current Psychiatry Reports 14 (2), S. 159 - 165 (2012)

Hartmann, J.; Wagner, K. V.; Liebl, C.; Scharf, S. H.; Wang, X. D.; Wolf, M.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C. et al.; Cheung-Flynn, J.; Cox, M. B.; Smith, D. F.; Holsboer, F.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62 (1), S. 332 - 339 (2012)

Wang, X.-D.; Labermaier, C.; Holsboer, F.; Wurst, W.; Deussing, J. M.; Müller, M. B.; Schmidt, M. V.: Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. European Journal of Neuroscience 36 (3), doi: 10.1111/j.1460-9568.2012.08148.x, S. 2360 - 2367 (2012)

Touma, C.; Gassen, N. C.; Herrmann, L.; Cheung-Flynn, J.; Büll, D. R.; Ionescu, I. A.; Heinzmann, J. M.; Knapman, A.; Siebertz, A.; Depping, A. M. et al.; Hartmann, J.; Hausch, F.; Schmidt, M. V.; Holsboer, F.; Ising, M.; Cox, M. B.; Schmidt, U.; Rein, T.: FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior. Biological Psychiatry 70 (10), S. 928 - 936 (2011)

Wang, X. D.; Rammes, G.; Kraev, I.; Wolf, M.; Liebl, C.; Scharf, S. H.; Rice, C. J.; Wurst, W.; Holsboer, F.; Deussing, J. M. et al.; Baram, T. Z.; Stewart, M. G.; Müller, M. B.; Schmidt, M. V.: Forebrain CRF(1) Modulates Early-Life Stress-Programmed Cognitive Deficits. Journal of Neuroscience 31 (38), S. 13625 - 13634 (2011)

Hartmann, J.; Wagner, K. V.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology 21 (Suppl. 3), S. S189 - S190 (2011)

Hartmann, J.; Wagner, K. V.; Liebl, C.; Wolf, M.; Scharf, S. H.; Wang, X. D.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C. et al.; Müller, M. B.; Schmidt, M. V.: The involvement of FKBP51 and FKBP52 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 44 (6), S. 294 - 294 (2011)

Scharf, S. H.; Liebl, C.; Binder, E. B.; Schmidt, M. V.; Müller, M. B.: Expression and regulation of the Fkbp5 gene in the adult mouse brain. Pharmacopsychiatry 44 (6), S. 305 - 305 (2011)

Wagner, K. V.; Hartmann, J.; Wang, X. D.; Liebl, C.; Wolf, M.; Scharf, S. H.; Kohl, C.; Marinescu, D.; Müller, M. B.; Schmidt, M. V.: The role of different Homer1 isoforms in acute and chronic social stress. Pharmacopsychiatry 44 (6), S. 310 - 310 (2011)

Kalueff, A. V.; Schmidt, M. V.: Novel experimental models and paradigms for neuropsychiatric disorders: Editorial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 (6), S. 1355 - 1356 (2011)